• Home
  • MCAN's 19% earnings jump proves mortgage impairments aren't the risk signal investors think they are
MCAN's 19% earnings jump proves mortgage impairments aren't the risk signal investors think they are
By Stephen Green profile image Stephen Green
3 min read

MCAN's 19% earnings jump proves mortgage impairments aren't the risk signal investors think they are

MCAN Financial Group logged a 19% net income gain in the first half of 2026 while simultaneously reporting a measurable uptick in impaired loans. That combination shouldn't exist, if you believe the standard read on credit quality.

The conventional story about rising impairments goes like this: defaults are the canary in the coal mine, the early warning that a lender's book is deteriorating, profitability is about to compress, and writedowns are coming. The market treats impairment figures like a countdown clock. MCAN's H1 results suggest that framing works better as a headline than as a predictive model.

The origination engine beat the impairment drag

MCAN's 19% earnings lift came from a surge in residential mortgage originations across both insured and uninsured products. The company operates as a Mortgage Investment Corporation, which means it avoids corporate income tax by distributing 100% of net income to shareholders. That structure makes it sensitive to origination volume in a way traditional banks are not. More loans written at higher yields in the first half of 2026 translated directly into distributable income, even as the share of loans showing payment trouble climbed.

The key here is timing. Impaired loans are a lagging indicator. They reflect mortgages originated months or years ago, many of which are now renewing at rates 300 to 400 basis points higher than their initial terms. The borrowers hitting trouble in mid-2026 locked in during 2021 and 2022, when qualifying was easier and rates were sub-2%. The loans MCAN is writing now are underwritten to a different stress test, at different rates, with different equity cushions. The impairment rate tells you about the old book. The earnings growth tells you about the new one.

Insured growth as defensive positioning

What makes MCAN's H1 performance more interesting is the split. Both insured and uninsured originations grew, but insured mortgages, where default risk transfers to CMHC or another insurer, saw notable volume increases. That's a hedge. Uninsured loans pay higher yields, which is why alternative lenders chase them, but they also carry full credit exposure. By growing the insured book alongside the uninsured one, MCAN is building a margin of safety into its portfolio mix at the exact moment impairments are trending up.

The regulatory backdrop matters here. OSFI's 2026 capital adequacy rules require lenders to set aside more provisions for credit losses as impaired loans rise. MCAN's insured origination growth lets it maintain volume and profitability without a proportional increase in capital requirements. The company is booking the revenue from higher originations while capping its downside exposure through insurance. That's not ignoring credit risk. That's managing around it.

The real risk isn't the impairment rate

The mistake most investors make when they see rising impairments is treating the number as a standalone risk metric. It isn't. What matters is whether the margin on new originations covers the cost of expected losses on the existing book, and whether the lender has enough capital buffer to absorb a tail scenario. MCAN's 19% earnings growth in a period of rising impairments suggests the answer to the first question is yes. The MIC structure, combined with the insured loan hedge, addresses the second.

The actual vulnerability in MCAN's book isn't the impairment rate today. It's the concentration risk that comes with being heavily exposed to Ontario and BC residential markets. If those two regions see localized downturns, employment shocks, sharp price corrections, extended oversupply, the impairment rate could accelerate faster than origination growth can offset. That's a portfolio composition problem, not an impairment-rate problem.

Impairments are information. They're not a forecast. MCAN's H1 results are a case study in why conflating the two leads to bad investment decisions.